CohBar, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CWBR research report →
About the company
CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging.
- CEO
- Pinchas Cohen Dean,
- IPO
- 2017
- Employees
- 9
- HQ
- Menlo Park, CA, US
Price Chart
- Market Cap
- $1.19M
- P/E
- -0.10
- P/S
- 0.00
- P/B
- 0.08
- EV/EBITDA
- 0.39
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -58.44%
- ROIC
- -79.39%
- Revenue
- $0 · 0.00%
- Net Income
- $-11,962,119 · 22.36%
- EPS
- $-4.13 · 40.49%
- Op Income
- $-12,388,297
- FCF YoY
- 27.74%
- 52W High
- $1.01
- 52W Low
- $0.00
- 50D MA
- $0.48
- 200D MA
- $0.54
- Beta
- 1.38
- Avg Volume
- 3.04K
Get TickerSpark's AI analysis on CWBR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 1, 22 | Biunno Jeffrey Francis | other | 26,203 |
| Aug 1, 22 | Sarret Joseph J. | other | 131,017 |
| Jul 11, 22 | Tozzo Stephanie | other | 200,000 |
| Jul 11, 22 | Tozzo Stephanie | other | 0 |
| Dec 29, 21 | Biunno Jeffrey Francis | other | 75,000 |
| Dec 29, 21 | Sarret Joseph J. | other | 650,000 |
| Nov 1, 21 | GREENWOOD DAVID | buy | 20,000 |
| Nov 1, 21 | GREENWOOD DAVID | buy | 20,000 |
| Nov 1, 21 | Barzilai Nir Yacov | buy | 13,889 |
| Nov 1, 21 | Barzilai Nir Yacov | buy | 13,889 |
Our CWBR coverage
Recent articles, reports, and earnings notes.
No research on CWBR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CWBR report →Similar companies
Peers in the same neighborhood.